Dr. Reddy's Laboratories Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Oct 2, 2024 · CIK: 1135951
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Dr. Reddy's filed a standard 6-K, no major news.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on October 2, 2024, reporting information as of October 1, 2024. The filing is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. The company is based in Hyderabad, India, and its fiscal year ends on March 31.
Why It Matters
This filing provides routine updates for foreign private issuers, ensuring transparency for investors regarding the company's regulatory compliance and reporting status.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001051 (filing_id) — Accession Number
- 20241001 (date) — Period of Report
- 20241002 (date) — Filing Date
- 0331 (date) — Fiscal Year End
- 001-15182 (company_id) — SEC File Number
FAQ
What type of filing is this for Dr. Reddy's Laboratories?
This is a Form 6-K, which is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing was made on October 2, 2024.
What is the period of report for this filing?
The period of report is October 1, 2024.
Where is Dr. Reddy's Laboratories principal executive office located?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-10-02 06:32:50
Filing Documents
- drr0677_6k.htm (6-K) — 14KB
- drr0677_ex99-1.htm (EX-99.1) — 17KB
- drr0677_ex99-1img01.jpg (GRAPHIC) — 7KB
- drr0677_ex99-1img02.jpg (GRAPHIC) — 6KB
- drr0677_ex99-1img03.jpg (GRAPHIC) — 7KB
- 0001575872-24-001051.txt ( ) — 60KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: October 1, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3